Emergent Biosolutions (UK) Analysis
| 0IGA Stock | 10.00 0.18 1.83% |
Emergent Biosolutions is overvalued with Real Value of 8.07 and Hype Value of 10.44. The main objective of Emergent Biosolutions stock analysis is to determine its intrinsic value, which is an estimate of what Emergent Biosolutions is worth, separate from its market price. There are two main types of Emergent Biosolutions' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Emergent Biosolutions' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Emergent Biosolutions' stock to identify patterns and trends that may indicate its future price movements.
The Emergent Biosolutions stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Emergent Biosolutions is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). Emergent Stock trading window is adjusted to Europe/London timezone.
Emergent |
Emergent Stock Analysis Notes
About 60.0% of the company shares are owned by institutions such as pension funds. The company had not issued any dividends in recent years. For more info on Emergent Biosolutions please contact Joseph Papa at 240 631 3200 or go to https://www.emergentbiosolutions.com.Emergent Biosolutions Quarterly Total Revenue |
|
Emergent Biosolutions Investment Alerts
| Emergent Biosolutions is way too risky over 90 days horizon | |
| Emergent Biosolutions appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.05 B. Net Loss for the year was (760.5 M) with profit before overhead, payroll, taxes, and interest of 290.1 M. | |
| Emergent Biosolutions generates negative cash flow from operations | |
| About 60.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Emergent BioSolutions Stock Surging Post Q3 Earnings Thanks To Papa Magic - citybiz |
Emergent Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 44.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Emergent Biosolutions's market, we take the total number of its shares issued and multiply it by Emergent Biosolutions's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Emergent Profitablity
Emergent Biosolutions' profitability indicators refer to fundamental financial ratios that showcase Emergent Biosolutions' ability to generate income relative to its revenue or operating costs. If, let's say, Emergent Biosolutions is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Emergent Biosolutions' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Emergent Biosolutions' profitability requires more research than a typical breakdown of Emergent Biosolutions' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. Management Efficiency
Emergent Biosolutions has return on total asset (ROA) of (0.0422) % which means that it has lost $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3464) %, meaning that it generated substantial loss on money invested by shareholders. Emergent Biosolutions' management efficiency ratios could be used to measure how well Emergent Biosolutions manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Emergent Biosolutions' Non Currrent Assets Other are comparatively stable compared to the past year. Other Assets is likely to gain to about 207.6 M in 2024, whereas Total Assets are likely to drop slightly above 1.2 B in 2024.Leadership effectiveness at Emergent Biosolutions is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin 0.2451 | Profit Margin (0.19) | Beta 1.574 | Return On Assets (0.04) | Return On Equity (0.35) |
Technical Drivers
As of the 28th of November, Emergent Biosolutions shows the Mean Deviation of 4.69, downside deviation of 6.69, and Coefficient Of Variation of 2102.7. Emergent Biosolutions technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Emergent Biosolutions mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if Emergent Biosolutions is priced favorably, providing market reflects its regular price of 10.0 per share.Emergent Biosolutions Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Emergent Biosolutions middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Emergent Biosolutions. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Emergent Biosolutions Predictive Daily Indicators
Emergent Biosolutions intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Emergent Biosolutions stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Emergent Biosolutions Forecast Models
Emergent Biosolutions' time-series forecasting models are one of many Emergent Biosolutions' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Emergent Biosolutions' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Emergent Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Emergent Biosolutions prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Emergent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Emergent Biosolutions. By using and applying Emergent Stock analysis, traders can create a robust methodology for identifying Emergent entry and exit points for their positions.
Emergent Biosolutions is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Emergent Biosolutions to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.